Oramed Pharmaceuticals Net Profit Margin 2011-2019 | ORMP
Oramed Pharmaceuticals net profit margin from 2011 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Oramed Pharmaceuticals Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2019-11-30 | $0.00B | $-0.01B | -325.00% |
| 2019-08-31 | $0.00B | $-0.01B | -350.00% |
| 2019-05-31 | $0.00B | $-0.02B | -375.00% |
| 2019-02-28 | $0.00B | $-0.02B | -375.00% |
| 2018-11-30 | $0.00B | $-0.01B | -350.00% |
| 2018-08-31 | $0.00B | $-0.01B | -325.00% |
| 2018-05-31 | $0.00B | $-0.01B | -325.00% |
| 2018-02-28 | $0.00B | $-0.01B | -275.00% |
| 2017-11-30 | $0.00B | $-0.01B | -275.00% |
| 2017-08-31 | $0.00B | $-0.01B | -275.00% |
| 2017-05-31 | $0.00B | $-0.01B | -433.33% |
| 2017-02-28 | $0.00B | $-0.01B | -650.00% |
| 2016-11-30 | $0.00B | $-0.01B | -1200.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.053B | $0.003B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $140.105B | 24.52 |
| Medtronic (MDT) | Ireland | $115.616B | 15.54 |
| Stryker (SYK) | United States | $55.501B | 17.93 |
| Boston Scientific (BSX) | United States | $43.519B | 19.60 |
| Baxter (BAX) | United States | $41.301B | 0.00 |
| Coloplast (CLPBY) | Denmark | $32.381B | 49.97 |
| Lonza Group Ag (LZAGY) | Switzerland | $30.517B | 0.00 |
| Terumo (TRUMY) | Japan | $24.814B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $23.088B | 0.00 |
| ResMed (RMD) | United States | $22.122B | 38.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.991B | 11.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.868B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $14.665B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.946B | 51.16 |
| Insulet (PODD) | United States | $10.367B | 634.31 |
| William Demant Holdings (WILYY) | Denmark | $7.898B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.034B | 20.23 |
| DiaSorin S.p.A (DSRLF) | Italy | $6.994B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $6.057B | 0.00 |
| Perrigo (PRGO) | Ireland | $6.039B | 11.01 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| Haemonetics (HAE) | United States | $4.949B | 30.46 |
| Canopy Growth (CGC) | Canada | $4.629B | 0.00 |
| ICU Medical (ICUI) | United States | $4.256B | 27.80 |
| Quidel (QDEL) | United States | $3.979B | 34.93 |
| Neogen (NEOG) | United States | $3.373B | 57.14 |
| Agios Pharmaceuticals (AGIO) | United States | $2.569B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $2.529B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.354B | 0.00 |
| NuVasive (NUVA) | United States | $2.269B | 17.54 |
| Envista Holdings (NVST) | United States | $2.062B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.337B | 22.53 |
| AtriCure (ATRC) | United States | $1.273B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.210B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.986B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.979B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.961B | 19.01 |
| NanoString Technologies (NSTG) | United States | $0.862B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.798B | 16.58 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.761B | 0.00 |
| Aphria (APHA) | $0.754B | 0.00 | |
| Cerus (CERS) | United States | $0.741B | 0.00 |
| Omeros (OMER) | United States | $0.663B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.639B | 79.31 |
| InMode (INMD) | Israel | $0.619B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.595B | 35.39 |
| PetIQ (PETQ) | United States | $0.582B | 15.83 |
| Quanterix (QTRX) | United States | $0.547B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.462B | 26.00 |
| Surmodics (SRDX) | United States | $0.432B | 49.69 |
| Owens & Minor (OMI) | United States | $0.427B | 11.69 |
| Lantheus Holdings (LNTH) | United States | $0.411B | 9.23 |
| Vapotherm (VAPO) | United States | $0.381B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.363B | 14.60 |
| Zynex (ZYXI) | United States | $0.327B | 35.61 |
| Repro-Med Systems (KRMD) | United States | $0.298B | 188.00 |
| Utah Medical Products (UTMD) | United States | $0.292B | 20.87 |
| Organigram Holdings (OGI) | Canada | $0.280B | 0.00 |
| MacroGenics (MGNX) | United States | $0.257B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.236B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.201B | 123.00 |
| Female Health (VERU) | United States | $0.196B | 0.00 |
| HEXO (HEXO) | $0.192B | 0.00 | |
| Viemed Healthcare (VMD) | United States | $0.164B | 18.52 |
| Exagen (XGN) | United States | $0.162B | 0.00 |
| United Health Products (UEEC) | United States | $0.132B | 0.00 |
| Evolus (EOLS) | United States | $0.130B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.124B | 0.00 |
| Bovie Medical (APYX) | United States | $0.122B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.121B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.110B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.105B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 6.78 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.069B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.062B | 0.00 |
| United-Guardian (UG) | United States | $0.061B | 12.69 |
| Nephros (NEPH) | United States | $0.058B | 0.00 |
| Surface Oncology (SURF) | United States | $0.047B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.037B | 0.00 |
| ImmuCell (ICCC) | United States | $0.030B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.024B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.024B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.023B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.010B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.005B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.002B | 0.00 |
